Today's Research Reports on CardioComm Solutions, Cipher Pharmaceuticals, Medicure and Aphria
NEW YORK, NY / ACCESSWIRE / January 17, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.
The Market Edge Initiates Coverage on:
CardioComm Solutions, Inc.
https://marketedgereport.com/report/EKG.V/
Cipher Pharmaceuticals Inc.
https://marketedgereport.com/report/CPH.TO/
Medicure Inc.
https://marketedgereport.com/report/MPH.V/
Aphria Inc.
https://marketedgereport.com/report/APHA.TO/
CardioComm Solutions' stock moved 11.11% lower Wednesday, to close the day at $0.04. The stock recorded a trading volume of 27,000 shares, which was below its three months average volume of 123,790 shares. In the last year, CardioComm Solutions' shares have traded in a range of 0.04 - 0.07. The share price has fallen 0% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.04 is lower than its 200-day moving average of $0.05.
Access The Market Edge's CardioComm Solutions, Inc. Research Report:
https://marketedgereport.com/report/EKG.V/
On Wednesday, shares of Cipher Pharmaceuticals recorded a trading volume of 141,863 shares, which was above the three months average volume of 44,809 shares. The stock ended the day 5.61% higher at $2.07. The share price has fallen 60.8% from its 52 week high with a 52 week trading range of 1.62 - 5.28. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.86 is lower than its 200-day moving average of $2.61. Shares of the company are trading at a Price to Earnings ratio of 10.30. Shares of Cipher Pharmaceuticals have gained approximately 23.21 percent year-to-date.
Access The Market Edge's Cipher Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/CPH.TO/
Medicure's stock moved 2.36% lower Wednesday, to close the day at $6.20. The stock recorded a trading volume of 8,703 shares, which was below its three months average volume of 12,160 shares. In the last year, Medicure's shares have traded in a range of 5.56 - 7.55. The share price has gained 11.51% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.20 is lower than its 200-day moving average of $6.67. Shares of the company are trading at a Price to Earnings ratio of 2.07. Shares of Medicure have gained approximately 0.98 percent year-to-date.
Access The Market Edge's Medicure Inc. Research Report:
https://marketedgereport.com/report/MPH.V/
On Wednesday, shares of Aphria recorded a trading volume of 4,709,633 shares, which was below the three months average volume of 11,194,024 shares. The stock ended the day 0.68% lower at $8.80. The share price has fallen 60% from its 52 week high with a 52 week trading range of 4.76 - 22.00. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $8.11 is lower than its 200-day moving average of $13.07. Shares of the company are trading at a Price to Earnings ratio of 22.11. Shares of Aphria have gained approximately 3.29 percent year-to-date.
Access The Market Edge's Aphria Inc. Research Report:
https://marketedgereport.com/report/APHA.TO/
Our Actionable Research on CardioComm Solutions, Inc. (TSXV :EKG.V), Cipher Pharmaceuticals Inc. (TSX :CPH.TO), Medicure Inc. (TSXV :MPH.V) and Aphria Inc. (TSX :APHA.TO) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge